Recent advances in structural mass spectrometry methods in the context of biosimilarity assessment: from sequence heterogeneities to higher order structures
J Castel, S Delaux, O Hernandez-Alba… - … of Pharmaceutical and …, 2023 - Elsevier
Biotherapeutics and their biosimilar versions have been flourishing in the biopharmaceutical
market for several years. Structural and functional characterization is needed to achieve …
market for several years. Structural and functional characterization is needed to achieve …
Unveiling the biological interface of protein complexes by mass spectrometry‐coupled methods
G Shin, SI Lim - Proteins: Structure, Function, and …, 2023 - Wiley Online Library
Most biomolecules become functional and bioactive by forming protein complexes through
interaction with ligands that are diverse in size, shape, and physicochemical properties. In …
interaction with ligands that are diverse in size, shape, and physicochemical properties. In …
[PDF][PDF] Inherited CDA-I disease: anemia-associated mutations disrupt CDIN1-Codanin1 complex
M Stojaspal, T Brom, I Nečasová, T Janovič… - bioRxiv 2023.05 …, 2024 - biorxiv.org
Congenital dyserythropoietic anemia type I (CDA-I) is a rare hereditary disease
characterized by ineffective erythropoiesis, spongy heterochromatin of erythroblasts, and …
characterized by ineffective erythropoiesis, spongy heterochromatin of erythroblasts, and …
Structural insights into inherited anemia CDA-I: disease-associated mutations disrupt CDIN1-Codanin1 complex
Congenital dyserythropoietic anemia type I (CDA-I) is a rare hereditary disease
characterized by ineffective erythropoiesis and associated mutations in two proteins …
characterized by ineffective erythropoiesis and associated mutations in two proteins …